| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.019 | 0.7 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.01 | 0.8 |